These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 581273
1. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798. Nicholson ML, Young DA. Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273 [Abstract] [Full Text] [Related]
2. Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake. Nicholson ML, Young DA. J Supramol Struct; 1979 Nov; 10(2):165-74. PubMed ID: 582325 [Abstract] [Full Text] [Related]
3. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798. Stevens J, Stevens YW. Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639 [Abstract] [Full Text] [Related]
4. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels. McPartland RP, Milholland RJ, Rosen F. Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163 [Abstract] [Full Text] [Related]
6. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798. Kaiser N, Milholland RJ, Rosen F. Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883 [No Abstract] [Full Text] [Related]
7. Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells. Nicholson ML, Voris BP, Young DA. Cancer Res; 1981 Sep; 41(9 Pt 1):3530-7. PubMed ID: 6894886 [Abstract] [Full Text] [Related]
8. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo. Chan AK, Thompson EA. J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232 [Abstract] [Full Text] [Related]
9. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes. Stevens J, Stevens YW. Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029 [Abstract] [Full Text] [Related]
10. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype. Thompson EA. Cancer Res; 1991 Oct 15; 51(20):5544-50. PubMed ID: 1913673 [Abstract] [Full Text] [Related]
11. Development of resistance to glucocorticoid hormones during rat thymus cell differentiation: proteins associated with emergence of the resistant state. Voris BP, Nicholson ML, Young DA. Cancer Res; 1983 Mar 15; 43(3):1236-43. PubMed ID: 6825095 [Abstract] [Full Text] [Related]
12. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798. Behrens UJ, Hollander VP. Cancer Res; 1976 Jan 15; 36(1):172-80. PubMed ID: 946164 [Abstract] [Full Text] [Related]
20. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response. Thompson EA. Cancer Res; 1991 Oct 15; 51(20):5551-6. PubMed ID: 1913674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]